Antibiotics are administered in approximately 71% of patients who are admitted to the intensive care unit (ICU) and have helped to save millions of lives [1]. However, up to half of all antibiotic prescriptions may be unnecessary [2]. Antibiotic overuse has contributed to alarmingly high levels of global antibiotic resistance, which is increasing at a rate faster than that at which novel antibiotics are produced. Therefore, finding a fine balance between the appropriate use and avoidance of unnecessary administration is crucial to prevent the renaissance of a new world without antibiotics [2].
Antibiotics clinical effects
Antibiotics largely reduce mortality associated with moderate and severe infections, with a historical number-needed-to-treat estimated in 5.3 for severe pneumonia patients [3]. Infection progressing to sepsis is the leading cause of death in ICU patients and can be potentially treated using antibiotics, along with organ dysfunction support, and infection source control [4]. From the cognitive dimension, the fear of patient deterioration due to sepsis favours the empirical use of antibiotics in ICU patients.
Once a severe infection is diagnosed, the early administration of broad-spectrum antibiotics is recommended to decrease the risk of death [4]. This intuitive recommendation is also based on observational studies that have been carried out in the emergency department [5, 6]. In contrast, a randomized study, showed that the pre-hospital administration of antibiotics in septic patients did not reduce the mortality [7]. Furthermore, in a prospective cohort of ICU patients with bacteremia, early initiation and appropriateness of antibiotic intervention were not found to impact mortality when adequately adjusted for confounders [8]. Additionally, a pooled analysis of the current literature failed to demonstrate a survival benefit related to antibiotic administration within the first hour or within the first 3 h following a diagnosis of sepsis [9].
In surgical and trauma patients, a quasi-experimental before and after study demonstrated that more aggressive antibiotic use had similar outcomes and higher antibiotic exposure compared to conservative use [10]. Interestingly, when antibiotics were administered following the diagnosis of shock (mean arterial pressure < 60 mmHg), the mortality of the aggressively-treated group was higher than that of the conservatively-treated group (66% vs. 25%, P < 0.0004). The authors presented several plausible factors to explain these findings. The adequacy of initial antibiotic treatment was lower in the aggressively-treated group, which therefore extended the antibiotics exposure. Moreover, the waiting time for blood cultures and observation of the clinical course may also disclose alternative diagnosis to infections. At last, up to 25% of patients initially diagnosed as septic shock did not have an identified infection 24 h after their initial diagnosis [11].
From the physiological point of view, there is no plausibility that minor time differences in antibiotic administration reduce the intensity of the inflammatory response, and may even be associated with a transient worsening after administration. Lastly, it is difficult to differentiate the effect of early antibiotic use per se from the awareness of critical illness and the timely institution of high quality-of-care [12].
Antibiotics adverse effects
Several adverse effects related to antibiotic use are described in the literature; with acquired multidrug resistance (MDR) being the most concerning effect. Since 1945, antibiotic resistance has been a major fear of Sir Alexander Fleming. Currently, MDR bacteria are largely spread across the world [13]. The real impact of MDRs on the outcomes of ICU patients is debatable, but despite this controversy, the incidence of MDRs is related to poor quality-of-care, as an expression of reduced compliance to hand hygiene [14], and a high burden of antibiotic exposure [15].
The de-escalation approach and single antibiotic dose impact
De-escalation approach, in which the antibiotic spectrum is narrowed or even withdrawn after re-evaluation, has been implemented to reduce exposure to antibiotics. De-escalation has proved to be safe in terms of survival; however, it is associated with an increased ICU length-of-stay, without reducing the incidence of MDRs [16]. De-escalation decreases the time of antibiotic use, but a short exposure still exists; in this way, a single antibiotic dose may be enough to treat severe infections such as meningococcal meningitis [17], and to promote profound and sustained microbiome unbalances, therefore facilitating opportunistic infections and damping the potential benefit of the de-escalation approach [18].
Stewardship programs, costs, microbiology and outcomes
The main step toward the reduction of antibiotic use is the adequacy of hand hygiene in healthcare professionals [14]. An antibiotic stewardship focusing on feedback, monitoring, persuasion, and audit after each drug prescription is associated with a long term reduction in healthcare associated infections, antibiotic prescriptions, and health care costs, without the deleterious effects on length-of-stay, readmissions, and in-hospital mortality [19]. Furthermore, the decrease in the use of carbapenems, has been associated with an overall reduction in the incidence of MDRs [15]
Antibiotics use mindset
To ensure patient safety, the early aggressive administration of broad-spectrum antibiotics in the ICU setting is common practice [4]. However, maintaining a conservative mindset with respect to antibiotic use and safety is fundamental to both the patient and environment. Mindset modification accomplishes many dimensions; for instance, the RESET model which has been applied to dairy cattle farms resulted in a reduction in antibiotic use in this area [20]. RESET dimensions are (1) (R)ules—an external motivation to reduce antibiotic prescription; (2) (E)ducation—showing that antibiotic prescriptions are unnecessarily excessive, expensive, and paradoxically unsafe; (3) (S)ocial pressure-ensuring societal awareness that unnecessary use of antibiotics is dangerously growing; (4) (E)conomics—the awareness of economic consequences of reduced use of antibiotics to save costs; and (5) (T)ools—ways to spread knowledge regarding the conscious use of antibiotics.
A schematic, aggressive, and conservative mindset to commence antibiotics is presented in Fig. 1.
There are several reasons why aggressive early use of broad-spectrum antibiotics should be avoided in ICU patients. Presence of shock without an alternative diagnosis other than infection, and a diagnosis of infection based on cultures, bacterioscopic examinations, and imaging results for the initiation of antibiotics is currently considered safe practice. Furthermore, clinicians can consider investigating feasible alternative diagnosis for shock in unstable ICU patients before antibiotics initiation. Consideration of antibiotic use in our ICUs is essential, and if necessary; there is great plausibility in changing our mindset to restrict antibiotic use.
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no conflicts of interest.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329. doi: 10.1001/jama.2009.1754. [DOI] [PubMed] [Google Scholar]
- 2.Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D, et al. Ready for a world without antibiotics? The Pensières antibiotic resistance call to action. Antimicrob Resist Infect Control. 2012;1(1):11. doi: 10.1186/2047-2994-1-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Evans GM, Gaisford W. Treatment of pneumonia with 2-(p-aminobenzenesulphonamido) pyridine. Lancet. 1938;232(5992):14–19. doi: 10.1016/S0140-6736(00)87996-9. [DOI] [Google Scholar]
- 4.Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304–377. doi: 10.1007/s00134-017-4683-6. [DOI] [PubMed] [Google Scholar]
- 5.Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, et al. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med. 2017;196(7):856–863. doi: 10.1164/rccm.201609-1848OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–1755. doi: 10.1097/CCM.0000000000000330. [DOI] [PubMed] [Google Scholar]
- 7.Alam N, Oskam E, Stassen PM, Exter PV, van de Ven PM, Haak HR, et al. Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med. 2018;6(1):40–50. doi: 10.1016/S2213-2600(17)30469-1. [DOI] [PubMed] [Google Scholar]
- 8.Corona A, Bertolini G, Lipman J, Wilson AP, Singer M. Antibiotic use and impact on outcome from bacteraemic critical illness: the BActeraemia Study in Intensive Care (BASIC) J Antimicrob Chemother. 2010;65(6):1276–1285. doi: 10.1093/jac/dkq088. [DOI] [PubMed] [Google Scholar]
- 9.Sterling SA, Miller WR, Pryor J, Puskarich MA, Jones AE. The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic review and meta-analysis. Crit Care Med. 2015;43(9):1907–1915. doi: 10.1097/CCM.0000000000001142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hranjec T, Rosenberger LH, Swenson B, Metzger R, Flohr TR, Politano AD, et al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis. 2012;12(10):774–780. doi: 10.1016/S1473-3099(12)70151-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Contou D, Roux D, Jochmans S, Coudroy R, Guérot E, Grimaldi D, et al. Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study. Crit Care. 2016;20(1):360. doi: 10.1186/s13054-016-1537-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kahn JM, Davis BS, Yabes JG, Chang CH, Chong DH, Hershey TB, et al. Association between state-mandated protocolized sepsis care and in-hospital mortality among adults with sepsis. JAMA. 2019;322(3):240–250. doi: 10.1001/jama.2019.9021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785–796. doi: 10.1016/S1473-3099(13)70190-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Derde LPG, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJL, Gniadkowski M, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis. 2014;14(1):31–39. doi: 10.1016/S1473-3099(13)70295-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Abdallah M, Badawi M, Alzaagi I, Issa KN, Rasheed A, Alharthy A. Effect of short-term carbapenem restriction on the incidence of non-pseudomonal multi-drug resistant Gram-negative bacilli in an intensive care unit. J Chemother. 2019;31:261. doi: 10.1080/1120009X.2019.1601802. [DOI] [PubMed] [Google Scholar]
- 16.Leone M, Bechis C, Baumstarck K, Lefrant JY, Albanèse J, Jaber S, et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med. 2014;40(10):1399–1408. doi: 10.1007/s00134-014-3411-8. [DOI] [PubMed] [Google Scholar]
- 17.Nathan N, Borel T, Djibo A, Evans D, Djibo S, Corty JF, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet. 2005;366(9482):308–313. doi: 10.1016/S0140-6736(05)66792-X. [DOI] [PubMed] [Google Scholar]
- 18.Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, Viale A, et al. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun. 2012;80(1):62–73. doi: 10.1128/IAI.05496-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Morris AM, Bai A, Burry L, Dresser LD, Ferguson ND, Lapinsky SE, et al. Long-term effects of phased implementation of antimicrobial stewardship in academic ICUs: 2007–2015. Crit Care Med. 2019;47(2):159–166. doi: 10.1097/CCM.0000000000003514. [DOI] [PubMed] [Google Scholar]
- 20.Lam TJGM, Jansen J, Wessels RJ. The RESET mindset model applied on decreasing antibiotic usage in dairy cattle in the Netherlands. Ir Vet J. 2017;70:5. doi: 10.1186/s13620-017-0085-x. [DOI] [PMC free article] [PubMed] [Google Scholar]